IMTX Competitors & Alternatives
Compare Immatics NV with similar stocks in the same industry
Biotechnology
IMTX
Main Stock$8.93
Tradestie Score
38
Market Cap
$1.09B
Revenue Growth
0.9%
Analyst Upside
+99.3%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.38
|
$1.22B | - | 50 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$7.20
|
$1.18B | - | 41 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$59.82
|
$1.17B | - | 46 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$21.07
|
$1.15B | 5.0 | 45 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$17.96
|
$1.14B | - | 53 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$14.20
|
$1.14B | - | 38 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$29.43
|
$1.13B | - | 49 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$5.29
|
$1.12B | - | 47 | Compare |
|
NKTR
Nektar Therapeutics
|
$74.02
|
$1.12B | - | 51 | Compare |
More IMTX Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry